ABL Diagnostics risk profile

36 Normal where most of the sector sits

Measured 21 October 2026 from ABLD.PA's filed statements. Recomputed nightly.

36 (Normal), driven by Market expectation at 82, over 5 weighted categories on the SOFTWARE profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation82AcuteVolatileOne-year price volatility — 93.7%
Operating pressure15ContainedEasingOperating-margin drift — +3.5 percentage points
Cash conversion34NormalEasingCapital spending against operating cash — 0.53x
Leverage and coverage18ContainedEasingNet debt to EBITDA — 1.15x
Competitive position35NormalStableRevenue-growth gap against peers — -31.1 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for ABL Diagnostics